In contrast, the activated CD8+ T cells differentiated from naïve CD8+ T cells, compared to those effector cells derived from memory CD8+ T cells, exhibit a better resistance to tumor‐induced immune suppression and reveal a more potent tumor‐specific cytotoxic activity.20 This evidence concerns the gene CD8A and neoplasm.